Delivery Order SPE2DR25D9331-SPE2DR26FQQS5
Award Date 4/13/26
Potential Completion Date 5/4/26
Potential Value $41K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $40,717.98 delivery order to DMS Pharmaceutical Group Inc. on April 13, 2026, for 3,750 units of Oncaspar (5 milliliter vials) with an ultimate completion date of May 4, 2026. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 million single-award indefinite delivery contract with a ceiling through December 31, 2036. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, for 3,750 units of Oncaspar 5 mL vials with a ceiling value of $40,717.98. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's indefinite delivery contract vehicle for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations globally. DMS Pharmaceutical Group is a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 24, 2026, for 3,750 units of Oncaspar 5 ml vials, with a ceiling value of $20,358.98. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract vehicle supporting recurring pharmaceutical supply for Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a...
- <p>The Defense Logistics Agency issued a $40,717.98 delivery order to DMS Pharmaceutical Group Inc. on March 9, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for 3,750 units of Oncaspar 5 ML vials.</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is firm fixed price with an ultimate completion date of March 30, 2026. Place of performance is Park Ridge, IL.</p>
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 23, 2026, with a ceiling value of $20,358.98 for 3,750 units of Oncaspar 5 milliliter vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, Illinois. The order is due April 13, 2026. This delivery order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 19, 2026, for oncology pharmaceutical supply (Oncaspar 3,750 unit/5 ml vials) with a ceiling value of $20,358.98. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 3,750 units of Oncaspar 5 ml vials valued at $40,717.98. The award, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, carries a firm fixed-price structure with no small business set-aside designation, indicating the contractor competed in open federal procurement. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,717.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on January 22, 2026. The delivery order covers 3,750 units of Oncaspar 5 milliliter vials, an oncology pharmaceutical product, with a firm fixed-price structure and an ultimate completion date of February 12, 2026. This award was issued without a set-aside designation, reflecting the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $27.4K by the Defense Logistics Agency's Medical Supply Chain for 3,750 units of Oncaspar 5 milliliter vials. The contract is firm fixed-price with no set-aside designation and an ultimate completion date of July 28, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $86,440.56 contract is for the supply of 3,750 units of the oncology medication Oncaspar (Pegaspargase) in 5 ML vials. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue...